ECTRIMS eLearning

Validation 'FES-I Falls Efficacy Scale' in spanish patients with multiple sclerosis (MS)
Author(s):
A. Granja Domínguez
,
A. Granja Domínguez
Affiliations:
A. Hochsprung
,
A. Hochsprung
Affiliations:
E. Magni
,
E. Magni
Affiliations:
S. Escudero Uribe
,
S. Escudero Uribe
Affiliations:
J. Schoffner
J. Schoffner
Affiliations:
ECTRIMS Learn. Granja Domínguez A. 09/14/16; 145665; EP1570
Anabel Granja Domínguez
Anabel Granja Domínguez
Contributions
Abstract

Abstract: EP1570

Type: ePoster

Abstract Category: Therapy - symptomatic - Quality of life

Background: MS affect the nervous system, wich gradually impacts the whole body and one of the consecuences are falls crashes. Although the risk for injury with each fall is similar for people with o without MS. Falls are a significant issue affecting a lot of people with MS. But it is not posible to clearly identify specific risk factors of falling. Evaluation of walking capacity, dynamic balance, and the risk of falls, therefore, are commonly performed in physiotherapy setting and provide information in justifying the need for individual treatments and planning treatments. Furthermore it needed a tool for predicting the risk of falls.

OBJETIVE: The aim of this study is validated this test in patients with MS to predict and quantify the risk of falls.

Methods: Descriptive study with a sample of 78 patients with relapsing- remitting (n=56) and secondary progressive (n=22) MS. (EDDS= 2-6). The age is between 23-56 years. 54 females and 24 men were recruited after meeting the inclusion/exclusion criterias. We registered the number of falls with verbal report in the last month and the patients did the FES-I test. At 15 days the retest was conducted.

Results: According to our hypothesis, patients classified as fallers scored over 70 % higher on the FES-I questionnaire compared to non-fallers 35.7 (S.D.= 11.0) vs. 20.7 (S.D= 7.7).

A greater number of falls corresponds a higher score in the scale FES-I. So it is a quantifiable tool for predicting the risk of falls.

Then we can include preventing the risk of falls in physiotherapy treatment.

Disclosure: Anabel Granja Dominguez: nothing to disclose

Abstract: EP1570

Type: ePoster

Abstract Category: Therapy - symptomatic - Quality of life

Background: MS affect the nervous system, wich gradually impacts the whole body and one of the consecuences are falls crashes. Although the risk for injury with each fall is similar for people with o without MS. Falls are a significant issue affecting a lot of people with MS. But it is not posible to clearly identify specific risk factors of falling. Evaluation of walking capacity, dynamic balance, and the risk of falls, therefore, are commonly performed in physiotherapy setting and provide information in justifying the need for individual treatments and planning treatments. Furthermore it needed a tool for predicting the risk of falls.

OBJETIVE: The aim of this study is validated this test in patients with MS to predict and quantify the risk of falls.

Methods: Descriptive study with a sample of 78 patients with relapsing- remitting (n=56) and secondary progressive (n=22) MS. (EDDS= 2-6). The age is between 23-56 years. 54 females and 24 men were recruited after meeting the inclusion/exclusion criterias. We registered the number of falls with verbal report in the last month and the patients did the FES-I test. At 15 days the retest was conducted.

Results: According to our hypothesis, patients classified as fallers scored over 70 % higher on the FES-I questionnaire compared to non-fallers 35.7 (S.D.= 11.0) vs. 20.7 (S.D= 7.7).

A greater number of falls corresponds a higher score in the scale FES-I. So it is a quantifiable tool for predicting the risk of falls.

Then we can include preventing the risk of falls in physiotherapy treatment.

Disclosure: Anabel Granja Dominguez: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies